{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:17:06Z","timestamp":1790378226488,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["PRE_2021_1_0166"],"award-info":[{"award-number":["PRE_2021_1_0166"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["2021111061"],"award-info":[{"award-number":["2021111061"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["LABAE211719BLAZ"],"award-info":[{"award-number":["LABAE211719BLAZ"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RYC2018-0243"],"award-info":[{"award-number":["RYC2018-0243"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CEX2023-001303-M"],"award-info":[{"award-number":["CEX2023-001303-M"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003989","name":"Ikerbasque, Basque Foundation for Science","doi-asserted-by":"publisher","award":["RF\/2019\/001"],"award-info":[{"award-number":["RF\/2019\/001"]}],"id":[{"id":"10.13039\/501100003989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003989","name":"Ikerbasque, Basque Foundation for Science","doi-asserted-by":"publisher","award":["RF\/2020"],"award-info":[{"award-number":["RF\/2020"]}],"id":[{"id":"10.13039\/501100003989","id-type":"DOI","asserted-by":"publisher"}]},{"name":"POLYMAT","award":["EMAKIKER"],"award-info":[{"award-number":["EMAKIKER"]}]},{"DOI":"10.13039\/501100003451","name":"Euskal Herriko Unibertsitatea","doi-asserted-by":"publisher","award":["GIU21\/033"],"award-info":[{"award-number":["GIU21\/033"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["2022\/IKER\/000006"],"award-info":[{"award-number":["2022\/IKER\/000006"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is a deadly brain tumor with a very poor prognosis. Development of new therapeutics is hindered by the lack of appropriate preclinical models that reflect the complexity of the tumor microenvironment, especially the crucial role of microglia. In this study, we investigated the impact of microglia on GBM models using humanized 3D spheroids. Homotypic and heterotypic spheroids were created out of a GBM-derived cell line (DKMG) or patient-derived glioma stem cells (GB22-13), along with a microglia cell line (HMC3). Heterotypic glioma-HMC3 spheroids exhibited increased proliferation and greater drug resistance to chemotherapy drug Temozolomide compared with homotypic spheroids. Heterotypic spheroids also grew larger, developed multinucleated structures within 7 days, and had a greater invasive potential. Additionally, a distinct core-shell structure emerged in the heterotypic spheroids, with glioma cells concentrated in the core and a surrounding layer of microglia forming a protective shell that appeared to hinder drug penetration to the tumor core. Further, heterotypic cells were able to induce migration and polarization of peripheral blood monocytes (THP-1) towards M2 phenotypes, increasing immune evasion. These findings highlight the critical role of microglia in GBM development and progression, demonstrating their contribution to both reduced drug diffusion and increased tumor growth.<\/jats:p>","DOI":"10.1038\/s41598-026-37395-0","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:36:28Z","timestamp":1770219388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["3D heterotypic models of glioblastoma reveal the impact of microglia on cellular organization and the production of a distinct secretome"],"prefix":"10.1038","volume":"16","author":[{"given":"Clara","family":"Garc\u00eda-S\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josune","family":"Alonso-Mara\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Garc\u00eda-Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Rubio-Zulaika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irati","family":"de Go\u00f1i-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorea","family":"Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Camarero-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"5","key":"37395_CR1","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1016\/j.clon.2023.01.012","volume":"35","author":"A Bosio","year":"2023","unstructured":"Bosio, A. et al. Metronomic Temozolomide in heavily pretreated patients with recurrent isocitrate dehydrogenase Wild-type glioblastoma: A large Real-Life Mono-Institutional study. Clin. Oncol. 35 (5), e319\u2013e27 (2023).","journal-title":"Clin. Oncol."},{"issue":"3","key":"37395_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neuron.2019.08.028","volume":"104","author":"D Gutmann","year":"2019","unstructured":"Gutmann, D. & Kettenmann, H. Microglia\/Brain macrophages as central drivers of brain tumor pathobiology. NEURON 104 (3), 442\u2013449 (2019).","journal-title":"NEURON"},{"key":"37395_CR3","doi-asserted-by":"crossref","unstructured":"Wallmann, T. et al. Microglia induce PDGFRB expression in glioma cells to enhance their migratory capacity. iScience. (2018).","DOI":"10.1016\/j.isci.2018.10.011"},{"key":"37395_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.isci.2018.10.011","volume":"9","author":"T Wallmann","year":"2018","unstructured":"Wallmann, T. et al. Microglia induce PDGFRB expression in glioma cells to enhance their migratory capacity. iScience 9, 71\u201383 (2018).","journal-title":"iScience"},{"key":"37395_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan, D., Gutmann, D. & Kettenmann, H. The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19, 20\u201327 (2016).","journal-title":"Nat. Neurosci."},{"issue":"4","key":"37395_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/AN20110011","volume":"3","author":"LC Huysentruyt","year":"2011","unstructured":"Huysentruyt, L. C., Akgoc, Z. & Seyfried, T. N. Hypothesis: are neoplastic macrophages\/microglia present in glioblastoma multiforme? Asn Neuro. 3 (4), 183\u2013193 (2011).","journal-title":"Asn Neuro"},{"key":"37395_CR7","doi-asserted-by":"crossref","unstructured":"Hutter, G. et al. Microglia are effector cells of CD47-SIRP\u03b1 antiphagocytic axis disruption against glioblastoma. Proc. Natl.  Acad. ci. (2019).","DOI":"10.1073\/pnas.1721434116"},{"key":"37395_CR8","doi-asserted-by":"crossref","unstructured":"Zhang, Z. M., Yang, Z. & Zhang, Z. Distribution and characterization of tumor-associated macrophages\/microglia in rat C6 glioma. Oncol. Lett. 2015-10-01;10(4).","DOI":"10.3892\/ol.2015.3533"},{"key":"37395_CR9","doi-asserted-by":"crossref","unstructured":"Juliano, J. et al. Comparative dynamics of microglial and glioma cell motility at the infiltrative margin of brain tumours. J. Royal Soc. Interface 15 (139). (2018).","DOI":"10.1098\/rsif.2017.0582"},{"key":"37395_CR10","doi-asserted-by":"crossref","unstructured":"Gieryng, A., Pszczolkowska, D., Walentynowicz, K. A., Rajan, W. D. & Kaminska, B. Immune microenvironment of gliomas. Lab. Invest. 97(5). (2017).","DOI":"10.1038\/labinvest.2017.19"},{"key":"37395_CR11","doi-asserted-by":"crossref","unstructured":"Chen, W. et al. Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14. Oncotarget 7(38). (2016).","DOI":"10.18632\/oncotarget.11515"},{"key":"37395_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cpt.2023.11.002","volume":"2","author":"X Niu","year":"2024","unstructured":"Niu, X., Zhang, Y. & Wang, Y. Co-culture models for investigating cellular crosstalk in the glioma microenvironment. Cancer Pathogenesis Ther.. 2, 219\u2013230 (2024).","journal-title":"CANCER PATHOGENESIS THERAPY"},{"issue":"6","key":"37395_CR13","doi-asserted-by":"publisher","first-page":"e13016","DOI":"10.1111\/nan.13016","volume":"50","author":"MD S\u00f8rensen","year":"2024","unstructured":"S\u00f8rensen, M. D. et al. Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to Temozolomide. Neuropathol. Appl. Neurobiol. 50 (6), e13016 (2024).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"37395_CR14","doi-asserted-by":"crossref","unstructured":"Heinrich, M. A., Huynh, N. T., Heinrich, L. & Prakash, J. Understanding glioblastoma stromal barriers against NK cell attack using tri-culture 3D spheroid model. Heliyon 10(3). (2024).","DOI":"10.1016\/j.heliyon.2024.e24808"},{"key":"37395_CR15","doi-asserted-by":"crossref","unstructured":"Darmanis, S. et al. Single-Cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell. Rep. (2017).","DOI":"10.1101\/165811"},{"issue":"6","key":"37395_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","volume":"4","author":"SM Pollard","year":"2009","unstructured":"Pollard, S. M. et al. Glioma stem cell lines expanded in adherent culture have Tumor-Specific phenotypes and are suitable for chemical and genetic screens. Cell. Stem Cell. 4 (6), 568\u2013580 (2009).","journal-title":"Cell. Stem Cell."},{"key":"37395_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/nprot.2016.037","volume":"11","author":"D Loessner","year":"2016","unstructured":"Loessner, D. et al. Functionalization, Preparation and use of cell-laden gelatin methacryloyl\u2013based hydrogels as modular tissue culture platforms. Nat. Protoc. 11, 4 (2016).","journal-title":"Nat. Protoc."},{"key":"37395_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan, D. et al. The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19, 1 (2016).","journal-title":"Nat. Neurosci."},{"key":"37395_CR19","doi-asserted-by":"crossref","unstructured":"Poon, M. T. C., Bruce, M., Simpson, J. E., Hannan, C. J. & Brennan, P. M. Temozolomide sensitivity of malignant glioma cell lines \u2013 a systematic review assessing consistencies between in vitro studies. BMC Cancer ;21(1). (2021).","DOI":"10.1186\/s12885-021-08972-5"},{"issue":"2","key":"37395_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jemt.1125","volume":"54","author":"B Badie","year":"2001","unstructured":"Badie, B. & Schartner, J. Role of microglia in glioma biology. Microsc. Res. Tech. 54 (2), 106\u2013113 (2001).","journal-title":"Microsc. Res. Tech."},{"key":"37395_CR21","doi-asserted-by":"crossref","unstructured":"Berens, E. B., Holy, J. M., Riegel, A. T. & Wellstein, A. A cancer cell spheroid assay to assess invasion in a 3D setting. J. Visualized Experiments: JoVE Nov 20(105). (2015).","DOI":"10.3791\/53409"},{"issue":"10","key":"37395_CR22","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald, A. C. et al. Integrative Spatial analysis reveals a multi-layered organization of glioblastoma. Cell 187 (10), 2485\u2013501e26 (2024).","journal-title":"Cell"},{"key":"37395_CR23","doi-asserted-by":"crossref","unstructured":"Li, J. et al. PI3K\u03b3 Inhibition suppresses microglia\/TAM accumulation in glioblastoma microenvironment to promote exceptional Temozolomide response. BioRxiv -05\u201316. (2020).","DOI":"10.1101\/2020.05.14.097121"},{"key":"37395_CR24","doi-asserted-by":"crossref","unstructured":"Ah-Pine, F. et al. On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells. Acta Neuropathol. Commun. 2023 11 1. 11(1). (2023).","DOI":"10.1186\/s40478-023-01605-x"},{"key":"37395_CR25","doi-asserted-by":"crossref","unstructured":"Wang, Q. et al. Tumor evolution of Glioma-Intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. (2017).","DOI":"10.1101\/052076"},{"key":"37395_CR26","doi-asserted-by":"crossref","unstructured":"Leite, D. M. et al. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics. FASEB J. 34(1). (2020).","DOI":"10.1096\/fj.201901858RR"},{"key":"37395_CR27","doi-asserted-by":"crossref","unstructured":"Huang, Y. et al. Microglia\/macrophage-derived human CCL18 promotes glioma progression via CCR8-ACP5 axis analyzed in humanized slice model. Cell. Rep. 39(2). (2022).","DOI":"10.1016\/j.celrep.2022.110670"},{"key":"37395_CR28","doi-asserted-by":"crossref","unstructured":"Gattas, M. J. et al. A heterotypic tridimensional model to study the interaction of macrophages and glioblastoma in vitro. Int. J. Mol. Sci. 2021, 22, (2021).","DOI":"10.3390\/ijms22105105"},{"issue":"2","key":"37395_CR29","first-page":"383","volume":"30","author":"Y Manome","year":"2010","unstructured":"Manome, Y. et al. Three-dimensional cell culture of glioma and morphological comparison of four different human cell lines. Anticancer Res. 30 (2), 383 (2010).","journal-title":"Anticancer Res."},{"key":"37395_CR30","doi-asserted-by":"crossref","unstructured":"Chen, J-W-E. et al. Crosstalk between microglia and patient-derived glioblastoma cells inhibit invasion in a three-dimensional gelatin hydrogel model. J. Neuroinflamm. (2020).","DOI":"10.1101\/2020.08.06.238345"},{"key":"37395_CR31","unstructured":"Hatzikirou, H., Basanta, D., Simon, M., Schaller, K. & Deutsch, A. \u2018Go or grow\u2019: the key to the emergence of invasion in tumour progression? Mathematical medicine and biology: J.  IMA. (2012)."},{"key":"37395_CR32","doi-asserted-by":"crossref","unstructured":"Oliveira, A. I. et al. Crosstalk between glial and glioblastoma cells triggers the go-or-grow phenotype of tumor cells. Cell. Communication Signal. (2017).","DOI":"10.1186\/s12964-017-0194-x"},{"issue":"2","key":"37395_CR33","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2021.11.FOCUS21589","volume":"52","author":"G Menna","year":"2022","unstructured":"Menna, G. et al. Immunoregulatory effects of glioma-associated stem cells on the glioblastoma peritumoral microenvironment: a differential PD-L1 expression from core to periphery? NeuroSurg. Focus. 52 (2), E4 (2022).","journal-title":"NeuroSurg. Focus"},{"issue":"2","key":"37395_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/neuonc\/noz189","volume":"22","author":"C Yu-Ju Wu","year":"2020","unstructured":"Yu-Ju Wu, C. et al. CCL5 of glioma-associated microglia\/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2. Neuro-Oncology 22 (2), 253\u2013266 (2020).","journal-title":"Neuro-Oncology"},{"key":"37395_CR35","doi-asserted-by":"crossref","unstructured":"Yang, K. et al. Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an Immunomodulatory microenvironment in glioblastoma. OncoImmunology (2022).","DOI":"10.1080\/2162402X.2022.2030020"},{"key":"37395_CR36","doi-asserted-by":"crossref","unstructured":"Zhao, W. et al. Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy. Npj Precision Oncol. 9:1. (2025).","DOI":"10.1038\/s41698-025-00920-x"},{"key":"37395_CR37","doi-asserted-by":"crossref","unstructured":"Carestia, A. et al. Platelets promote macrophage polarization toward Pro-inflammatory phenotype and increase survival of septic mice. Cell. Rep. (2019).","DOI":"10.1016\/j.celrep.2019.06.062"},{"key":"37395_CR38","doi-asserted-by":"crossref","unstructured":"Rodriguez, A., Gibo, D. & Debinski, W. ME-18: Induction of m2 type macrophages by GBM Cells. Neuro-Oncol. 16 (2014). (Suppl 5).","DOI":"10.1093\/neuonc\/nou261.17"},{"key":"37395_CR39","doi-asserted-by":"crossref","unstructured":"Scobie, M. R. et al. Differential transcriptome responses in human THP-1 macrophages following exposure to T98G and LN-18 human glioblastoma secretions: A simplified bioinformatics approach to Understanding Patient-Glioma-Specific effects on Tumor-Associated macrophages. Int. J. Mol. Sci. 2023, 24, (2023).","DOI":"10.3390\/ijms24065115"},{"key":"37395_CR40","doi-asserted-by":"crossref","unstructured":"Daga, A., Bottino, C., Castriconi, R., Gangemi, R. & Ferrini, S. New perspectives in glioma immunotherapy. Curr. Pharm. Design 17(23). (2011).","DOI":"10.2174\/138161211797249206"},{"key":"37395_CR41","doi-asserted-by":"crossref","unstructured":"Kielczewski, J. L. et al. Novel protective properties of IGFBP-3 result in enhanced pericyte Ensheathment, reduced microglial Activation, increased microglial Apoptosis, and neuronal protection after ischemic retinal injury. Am. J. Pathol. 2011\/04\/01;178(4).","DOI":"10.1016\/j.ajpath.2010.12.031"},{"key":"37395_CR42","doi-asserted-by":"crossref","unstructured":"Faisal, S. M. et al. Immune-stimulatory (TK\/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas. Oncotarget 2020-12-15;11(50).","DOI":"10.18632\/oncotarget.27834"},{"key":"37395_CR43","doi-asserted-by":"crossref","unstructured":"Cueto, F. J., Sancho, D., Cueto, F. J. & Sancho, D. The Flt3L\/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy. Cancers (2021).","DOI":"10.3390\/cancers13071525"},{"key":"37395_CR44","doi-asserted-by":"crossref","unstructured":"Srivastava, S. et al. A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials. Cancers (2019).","DOI":"10.3390\/cancers11040537"},{"key":"37395_CR45","doi-asserted-by":"crossref","unstructured":"Okada, M. et al. Tumor-associated macrophage\/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int. J. Oncol. 2009-06-01;34(6).","DOI":"10.3892\/ijo_00000292"},{"key":"37395_CR46","doi-asserted-by":"crossref","unstructured":"Mangano, K. et al. Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. Oncotarget 2018-04-03;9(25).","DOI":"10.18632\/oncotarget.24885"},{"key":"37395_CR47","doi-asserted-by":"crossref","unstructured":"Fritz, L. et al. Adv. Care Plann. Glioblastoma Patients Cancers 2016, 8, (2016).","DOI":"10.3390\/cancers8110102"},{"key":"37395_CR48","doi-asserted-by":"crossref","unstructured":"Maru, S. V. et al. Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation. J. Neuroimmunol. (2008).","DOI":"10.1016\/j.jneuroim.2008.04.029"},{"key":"37395_CR49","doi-asserted-by":"crossref","unstructured":"Cao, C. et al. Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma. Neoplasia (2025).","DOI":"10.1016\/j.neo.2025.101156"},{"key":"37395_CR50","doi-asserted-by":"crossref","unstructured":"Kohanbash, G. et al. GM-CSF promotes the immunosuppressive activity of Glioma-Infiltrating myeloid cells through Interleukin-4 Receptor-\u03b1. Cancer Res. (2013)..","DOI":"10.1158\/0008-5472.CAN-12-4124"},{"key":"37395_CR51","doi-asserted-by":"crossref","unstructured":"Albulescu, R. et al. Cytokine patterns in brain tumour progression. Mediat. Inflamm. (2013).","DOI":"10.1155\/2013\/979748"},{"key":"37395_CR52","doi-asserted-by":"crossref","unstructured":"Willis, E. F. et al. Repopulating microglia promote brain repair in an IL-6-Dependent manner. Cell (2020).","DOI":"10.1016\/j.cell.2020.02.013"},{"key":"37395_CR53","doi-asserted-by":"crossref","unstructured":"Kerber, M. et al. Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res. (2008).","DOI":"10.1158\/0008-5472.CAN-07-6241"},{"key":"37395_CR54","unstructured":"Turkowski, K. et al. VEGF as a modulator of the innate immune response in glioblastoma. Glia (2008)."},{"key":"37395_CR55","doi-asserted-by":"crossref","unstructured":"Cenciarelli, C. et al. PDGFR\u03b1 depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals. Oncotarget (2016).","DOI":"10.18632\/oncotarget.10132"},{"key":"37395_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/cddis.2013.283","volume":"4","author":"D Biasoli","year":"2013","unstructured":"Biasoli, D. et al. Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to Etoposide. Cell Death Dis. 4, 8 (2013).","journal-title":"Cell Death Dis."},{"key":"37395_CR57","doi-asserted-by":"crossref","unstructured":"Kikuchi, A., Matsumoto, S. & Sada, R. Dickkopf signaling, beyond Wnt-mediated biology. Semin. Cell Dev. Biol. (2022).","DOI":"10.1016\/j.semcdb.2021.11.003"},{"key":"37395_CR58","doi-asserted-by":"crossref","unstructured":"Zhu, G. et al. Expression and role of Dickkopf-1 (Dkk1) in tumors: from the cells to | CMAR. Cancer Manage. Res. (2021).","DOI":"10.2147\/CMAR.S275172"},{"key":"37395_CR59","doi-asserted-by":"crossref","unstructured":"Grass, G. D. & Toole Bryan, P. How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci. Rep. (2016).","DOI":"10.1042\/BSR20150256"},{"key":"37395_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep32804","volume":"6","author":"X Xin","year":"2016","unstructured":"Xin, X. et al. CD147\/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis. Sci. Rep. 6, 1 (2016).","journal-title":"Sci. Rep."},{"key":"37395_CR61","doi-asserted-by":"crossref","unstructured":"Tarassishin, L., Casper, D. & Lee, S. C. Aberrant expression of Interleukin-1\u03b2 and inflammasome activation in human malignant gliomas. PLOS ONE 23 9(7). (2014).","DOI":"10.1371\/journal.pone.0103432"},{"key":"37395_CR62","doi-asserted-by":"crossref","unstructured":"Litmanovich, A. et al. The role of Interleukin-1 in the pathogenesis of cancer and its potential as a therapeutic target in clinical practice. Oncol. Ther. (2018).","DOI":"10.1007\/s40487-018-0089-z"},{"key":"37395_CR63","doi-asserted-by":"crossref","unstructured":"Shnaper, S. et al. Elevated levels of MIC-1\/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. Int. J. Cancer (2009).","DOI":"10.1002\/ijc.24639"},{"key":"37395_CR64","doi-asserted-by":"crossref","unstructured":"Liu, E. et al. Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme. Trans. Oncol. (2023).","DOI":"10.1016\/j.tranon.2023.101739"},{"key":"37395_CR65","doi-asserted-by":"crossref","unstructured":"Wen, J. et al. Engineered nanovesicles targeting SERPINE1 overcome Temozolomide resistance in glioblastoma. Cell. Signal. (2025).","DOI":"10.1016\/j.cellsig.2025.111763"},{"key":"37395_CR66","doi-asserted-by":"crossref","unstructured":"Guo, X. et al. Glial-Cell-Line-Derived neurotrophic factor promotes glioblastoma cell migration and invasion via the SMAD2\/3-SERPINE1-Signaling axis. Int. J. Mol. Sci., 25, (2024).","DOI":"10.3390\/ijms251810229"},{"key":"37395_CR67","doi-asserted-by":"crossref","unstructured":"Maybee, D. V. et al. Novel roles of MT1-MMP and MMP-2: beyond the extracellular milieu. Int. J. Mol. Sci., 23, (2022).","DOI":"10.20944\/preprints202206.0305.v1"},{"key":"37395_CR68","doi-asserted-by":"crossref","unstructured":"Nikkola, J. et al. High serum levels of matrix Metalloproteinase-9 and matrix Metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin. Cancer Res. (2005).","DOI":"10.1158\/1078-0432.CCR-04-2478"},{"key":"37395_CR69","doi-asserted-by":"crossref","unstructured":"Szulzewsky, F. et al. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment. Neuro-Oncology  (2018).","DOI":"10.1093\/neuonc\/nox165"},{"key":"37395_CR70","doi-asserted-by":"crossref","unstructured":"Kijewska, M. et al. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Oncotarget 8(10) (2016).","DOI":"10.18632\/oncotarget.14092"},{"key":"37395_CR71","doi-asserted-by":"crossref","unstructured":"Cheng, V. W. T. et al. VCAM-1\u2013targeted MRI improves detection of the Tumor-brain interface. Clin. Cancer Res. (2022).","DOI":"10.1158\/1078-0432.22488261.v1"},{"key":"37395_CR72","doi-asserted-by":"crossref","unstructured":"Gilder, A. S. et al. The urokinase receptor induces a mesenchymal gene expression signature in glioblastoma cells and promotes tumor cell survival in neurospheres. Sci. Rep. (2018).","DOI":"10.1038\/s41598-018-21358-1"},{"key":"37395_CR73","unstructured":"Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. (2010)."},{"key":"37395_CR74","doi-asserted-by":"crossref","unstructured":"Lester, R. D., Jo, M., Montel Vr, Takimoto, S. & Gonias, S. L. uPAR induces epithelial\u2013mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol. (2007).","DOI":"10.1083\/jcb.200701092"},{"issue":"1","key":"37395_CR75","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","volume":"15","author":"M Genin","year":"2015","unstructured":"Genin, M., Clement, F., Fattaccioli, A., Raes, M. & Michiels, C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to Etoposide. BMC Cancer. 15 (1), 577 (2015).","journal-title":"BMC Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37395-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:16:19Z","timestamp":1771586179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37395-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37395"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37395-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7246"}}